Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21090481 | 0.84 | MAPT (0.47) | MAPTRECQLKMT2AMCL1RXFP1 | |
| SCHEMBL22746641 | 0.84 | MAPT (0.38) | MAPTRECQLKMT2AMCL1RXFP1 | |
| SCHEMBL19245114 | 0.74 | GSK3B (0.39) | MAPTRECQLKMT2AKDM4EALDH1A1 | |
| SCHEMBL11496736 | 0.68 | MAPT (0.47) | MAPTRECQLKMT2AKDM4EALDH1A1 | |
| SCHEMBL22252618 | 0.68 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL1240771 | 0.67 | ALDH1A1 (0.44) | MAPTRECQLKMT2ADRD2KDM4E | |
| SCHEMBL21090302 | 0.66 | BCHE (0.42) | MAPTKDM4EALDH1A1 | |
| SCHEMBL21090301 | 0.66 | BCHE (0.42) | MAPTKMT2ADRD2KDM4EALDH1A1 | |
| SCHEMBL19861187 | 0.65 | VDR (0.35) | MAPTKMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL1580661 | 0.65 | TDP1 (0.44) | KMT2AMCL1DRD2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220119293-A1 | METHOD OF CONTROLLING SCALE IN AQUEOUS SYSTEMS | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2022-04-21 | — | — | US | disclosed |
| US-11208408-B2 | Method of controlling scale in aqueous systems | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2021-12-28 | — | — | US | disclosed |
| US-20210253461-A1 | METHOD OF CONTROLLING SCALE IN AQUEOUS SYSTEMS | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2021-08-19 | — | — | US | disclosed |
| WO-2020243180-A1 | METHOD OF CONTROLLING CARBONATE SCALE IN AQUEOUS SYSTEMS | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2020-12-03 | — | — | WO | disclosed |
| WO-2020243176-A1 | METHOD OF CONTROLLING SCALE IN AQUEOUS SYSTEMS | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2020-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11208408-B2 | Method of controlling scale in aqueous systems | FGB, F2, F10 | MAPT 2981/4885RECQL 2891/4885KMT2A 3747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.